Decoding 17 Analyst Evaluations For Intel

Throughout the last three months, 17 analysts have evaluated Intel (NASDAQ:INTC), offering a diverse set of opinions from bullish to bearish. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing…

The Latest Analyst Ratings For Ligand Pharmaceuticals

8 analysts have expressed a variety of opinions on Ligand Pharmaceuticals (NASDAQ:LGND) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changi…